The Defense Threat Reduction Agency, Atala and the Wake Forest Institute for Regenerative Medicine are teaming to create a tool to build interconnected organoids within the body, DVIDS reported Tuesday. The Integrated Organoid Testing System utilizes 3D printed bio-structures, microfluidic devices and human organ cells to try to develop organs with regenerative capacities.
DTRA intends to use the technology to manufacture miniaturized organoid systems that may forecast a drug candidate’s tolerance prior to clinical trials. The agency has also started to build organoid systems from animal models at WFIRM to assist researchers in the development of countermeasures against biological and chemical warfare.
